Tiagabine approved for partial seizures.
D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004828:Epilepsies, Partial / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D009557:Nipecotic Acids / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000078308:Tiagabine
D000927:Anticonvulsants; D009557:Nipecotic Acids; D000078308:Tiagabine